India's Lupin Q4 profit up 48 pct, beats estimates

MUMBAI, May 19 (Reuters) - Lupin Ltd, India's

third-largest drugmaker, reported a 48 percent rise in quarterly

net profit, outpacing analysts' estimates mainly due to higher

drug sales in its largest market, the United States.

Read more